24 May 2013
Keywords: il2, uncertain, renal, cell, carcinoma, aldesleukin, recombinant
Article | 03 May 1993
Aldesleukin (recombinant interleukin 2: Proleukin - EuroCetus), which was recently launched in the UK for metastatic renal cell carcinoma as a 24 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.